USA - NASDAQ:XRX - US98421M1062 - Common Stock
ChartMill assigns a Buy % Consensus number of 47% to XRX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-18 | Citigroup | Reiterate | Neutral |
| 2024-10-30 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-10-30 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2024-10-21 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-08-14 | Loop Capital | Maintains | Hold -> Hold |
| 2024-06-28 | Citigroup | Initiate | Sell |
| 2024-04-24 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-01-26 | JP Morgan | Maintains | Underweight -> Underweight |
| 2023-10-25 | JP Morgan | Maintains | Underweight -> Underweight |
| 2023-10-25 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-07-26 | Credit Suisse | Maintains | Underperform -> Underperform |
| 2023-07-26 | Morgan Stanley | Reiterate | Underweight -> Underweight |
| 2023-04-26 | Morgan Stanley | Maintains | Underweight |
| 2022-10-26 | Citigroup | Maintains | Sell |
| 2022-10-18 | Credit Suisse | Maintains | Underperform |
| 2022-10-17 | Morgan Stanley | Maintains | Underweight |
| 2022-08-17 | Credit Suisse | Initiate | Underperform |
| 2022-07-27 | Morgan Stanley | Maintains | Underweight |
| 2022-07-14 | JP Morgan | Maintains | Underweight |
| 2022-04-22 | Morgan Stanley | Maintains | Underweight |
| 2022-04-22 | Citigroup | Maintains | Sell |
| 2021-09-23 | Morgan Stanley | Initiate | Underweight |
11 analysts have analysed XRX and the average price target is 7.96 USD. This implies a price increase of 122.95% is expected in the next year compared to the current price of 3.57.
The consensus rating for XEROX HOLDINGS CORP (XRX) is 47.2727 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering XEROX HOLDINGS CORP (XRX) is 11.